Non P-glycoprotein novel proteins involved in human cancer multidrug resistance

Bulletin du Cancer

Volumn 84, Issue 4, 1997, Pages 385-390

  Baggetto, Loris G ^a  

^a INSTITUT DE BIOLOGIE ET CHIMIE DES PROTÉINES   (France)

Author keywords

human cancer; lung resistance protein (LRP); membrane protein P 95; multidrug resistance; multidrug resistance related protein (MRP)

Indexed keywords

GLYCOPROTEIN P; MULTIDRUG RESISTANCE RELATED PROTEIN; UNCLASSIFIED DRUG;

CANCER; HUMAN; MULTIDRUG RESISTANCE; REVIEW;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CHROMOSOME MAPPING; CRICETINAE; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION; HUMANS; MEMBRANE GLYCOPROTEINS; MICE; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; P-GLYCOPROTEIN; PHENOTYPE; TUMOR CELLS, CULTURED;

EID: 0030983599     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. Juliano RL, Ling V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 1976; 455: 152-62.
2. Dong M, Penin F, Baggetto LG. Complete purification of P-glycoprotein for functional and structural studies. J Biol Chem 1996; 271: 28875-84.
3. Ueda K, Cornwell MM, Gottesman MM, Pastan I, Roninson IB, Ling V, Riordan JR. The mdr1 gene, responsible for multidrug-resistance, codes for P-glycoprotein. Biochem Biophys Res Commun 1986; 141: 956-62.
4. Gros P, Raymond M, Housman D. Cloning and characterization of mouse mdr genes. In: Roninson IB, ed. Molecular and cellular biology of multidrug resistance in tumor cells. New York: Plenum Press, 1991; 73-90.
5. Roninson IB, Pastan I, Gottesman MM. Isolation and characterization of the human MDR (P-glycoprotein) genes. In: Roninson IB, ed. Molecular and cellular biology of multidrug resistance in tumor cells. New York: Plenum Press, 1991; 91-106.
6. Kane SE, Pastan I, Gottesman MM. Genetic basis of multidrug resistance of tumor cells. J Bioenerg Biomembr 1990; 22: 593-618.
7. Cole SPC, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 1992; 258: 1650-4.
8. Croop JM, Raymond M, Haber D, Devault A, Arceci RJ, Gros P, Housman DE. The three mouse multidrug resistant genes are expressed in a tissue-specific manner in normal mouse tissues. Mol Cell Biol 1989; 9: 1346-50.
9. Chin JE, Soffir R, Noonan KE, Choi K, Roninson IB. Structure and expression of the human MDR (P-glycoprotein) gene family. Mol Cell Biol 1989; 9: 3808-20.
10. Raymond M, Rose E, Housman DE, Gros P. Physical mapping, amplification, and overexpression of the mouse mdr gene family in multidrug-resistant cells. Mol Cell Biol 1990; 10: 1642-51.
11. Childs S, Yeh RL, Ling V. Identification of a sister gene to P-glycoprotein. Cancer Res 1996; 55: 2029-34.
12. Norris MD, Gilbert J, Madafiglio J, Haber M. Analysis of a novel cDNA encoding a C219-reactive peptide from methotrexate-selected multidrug-resistant human leukemic cells. Gene 1995; 156: 313-4.
13. Kawai K, Kusano I, Ido M, Sakurai M, Shiraishi T, Ytani R. Identification of a P-glycoprotein-related (mini-P-glycoprotein) which is overexpressed in multidrug resistant cells. Biochem Biophys Res Commun 1994; 198: 804-10.
14. Zaman G, Flens MJ, Van LM, De HM, Mülder HS, Lankelma J, et al. The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc Natl Acad Sci USA 1994; 91: 8822-6.
15. Hipfner DR, Gauldie SD, Deeley RG, Cole S. Detection of the Mr 190,000 multidrug resistance protein, MRP, with monoclonal antibodies. Cancer Res 1994; 54: 5788-92.
16. Krishnamachary N, Ma L, Zheng L, Safa AR, Center MS. Analysis of MRP gene expression and function in HL60 cells isolated for resistance to adriamycin. Oncology Res 1994; 6: 119-27.
17. Zhu Q, Center MS. Cloning and sequence analysis of the promoter region of the MRP gene of HL60 cells isolated for resistance to adriamycin. Cancer Res 1994; 54: 4488-92.
18. Krishnamachary N, Center MS. The MRP gene associated with a non-P-glycoprotein multidrug resistance encodes a 190-kDa membrane bound glycoprotein. Cancer Res 1993; 53: 3658-61.
19. Cole S, Sparks KE, Fraser K, Loe DW, Grant CE, Wilson GM, Deeley RG. Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res 1994; 54: 5902-10.
20. Almquist KC, Loe DW, Hipfer DR, Mackie JE, Cole SPC, Delley RG. Characterization of the Mr 190,000 multidrug resistance protein (MRP) in drug selected and transfected human tumor cell. Cancer Res 1995; 55: 102-10.
21. Ma L, Krishnamachary N, Center MS. Phosphorylation of the multidrug resistance associated protein gene encoded protein P190. Biochemistry 1995; 34: 32338-43.
22. Barrand MA, Heppel-Parton AC, Wright KA, Rabbits PH, Twentyman PR. A 190-kilodalton protein overexpressed in non-P-glycoprotein-containing multidrug-resistant cells and its relationship to the MRP gene. J Natl Cancer Inst 1994; 86: 110-17.
23. Slovak ML, Ho JP, Cole SPC, Deeley RG, Greenberger L, de Vires EGE, et al. The LRP gene encoding a major vault protein associated with drug resistance maps proximal to MRP on chromosome 1: evidence that chromosome breakage plays a role in MRP or LRP gene amplification. Cancer Res 1995; 55: 4214-9.
24. Kavallaris M, Leary JA, Barrett JA, Friedlander ML. MDR1 and multidrug resistance-associated protein (MRP) gene expression in epithelial ovarian tumors. Cancer Lett 1996; 102: 7-16.
25. Chuman Y, Sumizawa T, Takebayashi Y, Niwa K, Yamada K, Haraguchi M, et al. Expression of the multidrug-resistance-associated protein (MRP) gene in human colorectal, gastric and non-small-cell lung carcinomas. Int J Cancer 1996; 66: 274-9.
26. Nooter K, Bosman FT, Burger H, Vanwingerden KE, Flens MJ, Scheper RJ, et al. Expression of the multidrug resistance-associated protein (MRP) gene in primary non-small-cell lung cancer. Ann Oncol 1996a; 7: 75-81.
27. Bordow SB, Haber M, Madafiglio J, Cheung B, Marshall GM, Norris MD. Expression of the multidrug resistance-associated protein (MRP) gene correlates with amplification and overexpression of the N-myc oncogene in childhood neuroblostoma. Cancer Res 1994; 54: 5036-40.
28. Oda Y, Schneiderstock R, Rys J, Gruchala A, Niezabitowski A, Roessner A. Expression of multidrug resistance associated protein gene in human soft-tissue sarcomas. J Cancer Res & Clin Oncol 1996; 122: 161-5.
29. Sugawara I, Masunaga A, Itoyama S, Sumizawa T, Akiyama S, Yamashita T. Expression of multidrug resistance-associated protein (MRP) in thyroid cancers. Cancer Lett 1995; 95: 135-8.
30. Eijdems EWHM, Zaman GJR, Dehaas M, Versantvoort CHM, Flens MJ, Scheper RJ, et al. Altered MRP is associated with multidrug resistance and reduced drug accumulation in human SW-1573 cells. Brit J Cancer 1995; 72: 298-306.
31. Nooter K, Burger H, Stoter G. Multidrug-resistonce-associated protein (MRP) in haematological malignancies. Leukemia & lymphoma 1996b; 20: 5-6.
32. Stewart AJ, Canitrot Y, Barracchini E, Dean NM, Deeley RG, Cole SPC. Reduction of expression of the multidrug resistance protein (MRP) in human tumor cells by antisense phosphorothioate oligonucleotides. Biochem Pharmacol 1996; 51: 461-9.
33. Loe DW, Almquist KC, Deeley RG, Cole SPC. Multidrug resistance protein (MRP)-mediated transport of leukotriene C-4 and chemotherapeutic agents in membrane vesicles - demonstration of glutathione-dependent vincristine transport. J Biol Chem 1996; 271: 9675-82.
34. Muller M., Devries EGE, Jansen PLM. Role of multidrug resistance protein (MRP) in glutathione S-conjugate transport in mammalian cells. J Hepatol 1996; 24 (suppl. 1): 100-8.
35. Loe DW, Almquist KC, Cole SPC, Deeley RG. ATP-dependent 17-beta-estradiol 17(beta-D-glucuronide) transport by multidrug resistance protein (MRP) - inhibition by cholestatic steroids. J Biol Chem 1996; 271: 9683-9.
36. Chen YN, Mickley LA, Scwartz AM, Acton EM, Hwang JL, Fojo AT. Characterization of adriamycin-resistant human breast cancer cells which display overexpression of a novel resistance-related membrane protein. J Biol Chem 1990; 265: 10073-80.
37. Doyle LA, Gao YM, Yang WD, Ross DD. Characterization of a 95 kilodalton membrane glycoprotein associated with multidrug resistance. Int J Cancer 1995; 62: 593-8.
38. Doyle LA, Yang WD, Rishi AK, Gao YM, Ross DD. H19 gene overexpression in atypical multidrug-resistant cells associated with expression of a 95-kilodalton membrane glycoprotein. Cancer Res 1996; 56: 2904-7.
39. Kim DK, Zhang L, Dzau VJ, Pratt RE. H19, a developmentally regulated gene, is reexpressed in rat vascular smooth muscle cells after injury. J Clin Invest 1994; 93: 355-60.
40. Hao Y, Crenshaw T, Moulton T, Newcomb E, Tycko B. Tumour-suppressor activity of H19 RNA. Nature 1994; 365: 764-7.
41. Scheper RJ, Broxterman HJ, Scheffer GL, Kaaijk P, Dalton WS, van Heijningen THM, et al. Overexpression of a M(r) 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. Cancer Res 1993; 53: 1475-9.
42. Slovak MK, Ho JP, Bhardwaj G, Jurz EU, Deeley RG, Cole SPC. Localization of a novel multidrug resistance-associated gene in the HT1080/DR4 and H69/AR human tumor cell lines. Cancer Res 1993; 53: 3221-5.
43. Scheffer GL, Wijngaard PLJ, Flens MJ, Izquierdo MA, Slovak ML, Pinedo HM, et al. The drug resistance-related protein LRP is a major vault protein. Nature Medicine 1995; 1: 578-82.
44. Kedersha NL, Rome LH. Isolation and characterization of a novel ribonucleoprotein particle: large structures contain a single species of small RNA. J Cell Biol 1986; 103: 699-709.
45. Chugani DC, Rome LH, Kedersha NL. Evidence that vault ribonucleoprotein particles localize to the nucleopore complex. J Cell Sci 1993; 106: 23-9.
46. Kedersha NL, Heuser JE, Chugani DC, Rome LH. Vaults III. Vault ribonucleoprotein particles open into flower-like structures with octagonal symmetry. J Cell Biol 1991; 112: 225-35.
47. Izquierdo MA, van der Zee AG, Vermoken JB, van der Valk P, Belien JA, Giaccone G, et al. Drug resistance-associated marker LRP for prediction of response to chemotherapy and prognoses in advanced ovarian carcinoma. J Natl Cancer Inst 1995; 87: 1230-7.
48. Schadendorf D, Makki A, Stahr C, Vandyck A, Wanner R, Scheffer GL, et al. Membrane transport proteins associated with drug resistance expressed in human melanoma. Am J Pathol 1995; 147: 1545-52.
49. Izquierdo MA, Scheffer GL, Flens MJ, Giaccone G, Broxterman HJ, Meijer CJLM, et al. Broad distribution of the multidrug resistance-related vault protein in normal human tissues and tumors. Am J Pathol 1996; 148: 877-87.
50. Kickhoefer VA, Vasu SK, Rome LH. Vaults are the answer, what is the question? Trends Cell Biol 1996; 6: 174-8.
51. Yelin R, Schuldiner S. The pharmacological profile of the vesicular monoamine transporter resembles that of multidrug transporters. FEBS Lett 1996; 377: 201-7.
52. Schuldiner S, Shirvan A, Linial M. Vesicular neurotransmitter transporters: from bacteria to humans. Physiol Rev 1995; 75: 369-92.
53. + toxicity encodes a vesicular amine transporter. Cell 1992; 70: 539-51.
54. O'Neill GM, Longhurst T, Harvie RM, Davey RA. A novel gene (ara) associated with drug resistance. Proc Am Assoc Cancer Res 1996; 37: 322.
55. Yamauchi T, Aster JC, Kufe DW, Slapak CA. Overexpression of a novel nucleotide-binding protein in anthracycline-resistant cells with growth inhibitory properties. Proc Am Assoc Cancer Res 1996; 37: 322.
56. Yang XW, Page M. An M(r) 7-kDa membrane protein overexpressed in human multidrug-resistant ovarian cancer cells. Cancer Lett 1995; 88: 171-8.
57. Kurdi-Haidar B, Aebi S, Heath D, Zheng H, Enns RE, Naredi P, et al. The novel human hARSA-I gene product mediates resistance to arsenite, cadmium, and nickel in human cells. Proc Am Assoc Cancer Res 1996; 37: 319.